🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07171151
Recruiting Observational

Detection of Disease Marker Factors in Cyst Fluid

NCT07171151 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2025-08-25
Last updated
2025-09-12

Condition(s) studied

Biomarkers

Investigational drug(s) / intervention(s)

cyst fluid examination

cyst fluid examination: Participants will not undergo any procedures outside of the routine for the study. The cyst fluid obtained during the puncture will be collected in a tube and centrifuged at 3000 rpm for 20 minutes at 4 degrees Celsius. The Eppendorf tubes will be stored at -80 °C until the clear liquid remaining above is taken and examined, without removing the particles that have settled at the bottom of the tube. The biochemical parameters of the cyst fluid obtained from the study participants will be analyzed using the ELISA method. MMP-8, MMP-9, RANKL, and MIP1alpha will be analyzed using commercially available ELISA kits, following the manufacturer's instructions.

Study summary

The purpose of this observational study is to examine the cyst fluid obtained after a puncture procedure performed for cyst diagnosis in participants with cystic lesions on clinical and radiological examination.The main question it aims to answer is:

\- What is the exact mechanism of formation of odontogenic cysts?

Biomarkers in the cyst fluid obtained after a puncture procedure performed as part of the diagnosis and treatment process of odontogenic cysts will be examined. The aim of this study is to gain insight into cyst pathology by examining the levels of biomarkers in odontogenic cyst fluid.

Eligibility

Sex
ALL
Min age
12 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: 1. Individuals diagnosed with cysts 2. Individuals who are not pregnant or breastfeeding 3. Individuals who agree to sign the informed consent form Exclusion Criteria: 1. Systemically ill individuals who are contraindicated for surgery. 2. Individuals who do not wish to sign the informed consent form. 3. Individuals who are pregnant, breastfeeding, or using oral contraceptives will be excluded.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Harran University, Faculty of Dentistry Sanliurfa Turkey (Türkiye) Recruiting

More Harran University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07171151 on ClinicalTrials.gov ↗ ← All trials in Turkey